Balanced news tone
News Sentiment
CANF sentiment intelligence
Can-Fite BioPharma Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
66/100 classification confidence.
directly relevant articles
high-authority source matches
-3.1% over one week, +8.7% over four weeks, trend inactive, and below fair value.
[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer) | CANF SEC Filing - Form 6-K
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
[6-K] Can-Fite BioPharma Ltd. Current Report (Foreign Issuer) | CANF SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 11:12
- Source
- Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Can Fite Biopharma (AMEX:CANF), Atlantic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 12:05
- Source
- Benzinga
Can-Fite BioPharma (CANF) Reports Positive Results in Namodenoso
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 01 Jul 2026 07:00
- Source
- GuruFocus